Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YCCEL1 |
Human gastric carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | virusproduction | Metafectene | publication | M.-H. Tsai et al., Oncotarget, 2017, 8 (6): 10238-10254 | Link | ||
XP12RO |
Human xeroderma pigmentosum cell line, SV40 immortalized | Human | skin | cell line | adherent | plasmid | Metafectene PRO | publication | S. Sertic et al., PNAS, Aug 2011; 108: 13647 - 13652 | Link | |||
WS-15 |
Human breast cancer cell line | Human | breast | cell line | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | |||
WM853 |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | ||
WM853 |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | ||
WM266-4 |
Human cutaneous metastatic melanoma cell line | ATTC CRL-1676 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Bubka et al., Biochimie, 2014, 103: 37-49, doi.org/10.1016/j.biochi.2014.04.003 | ||
WiDr |
Human colorectal adenocarcinoma cell line | ATCC CCL-218 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | P. Suboj et al., Pharmacology, 2012, 89: 91–98, DOI: 10.1159/000335659 | ||
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
UMel-2 |
Human primary ciliry body melanoma cells | Human | skin | primary cell | adherent | plasmid | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | ||||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene EASY | publication | J. C. Romero Sandoval, PhD Thesis, 2014, Universitat de Barcelona | Link | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., Jul 2015; 290: 17894 - 17908 | |||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | S. M. Figueroa, Tesis Doctoral, 2021, Universidad Complutense de Madrid | Link | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Y. Tomioka et al., J. Gen. Virol., Mar 2004; 85: 647 - 652 | Link | ||
U343 |
Human malignant astrocytoma cell line | Human | brain | cell line | plasmid | Metafectene | publication | V. Voss et al., Mol. Cancer Res., Jul 2010; 8: 1002 - 1016 | Link | ||||
U2OS 2-6-3 |
Human bone osteosarcoma cell line (derivat of U2OS) | Human | bone | cell line | adherent | plasmid | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | |||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | Y. Martin et al., Oncogene, 2015, 34:1058-1063; doi:10.1038/onc.2014.38 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Hernández-Pérez et al., Oncogene, 2017, 36: 4802 4809, doi:10.1038/onc.2017.21 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. M. Davies, PhD Thesis, 2015, University of Dundee | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. I. Sheikh et al., Translat. Psychiatry, 2021,1 1:1, doi.org/10.1038/s41398-020-01158-w | Link |